{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T21:18:52.553886+00:00","published_at":"2026-10-16T13:51:55.971604+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:5:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:barry-d-quart-pharm-d","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Barry D. Quart, Pharm.D.","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:6:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:felix-j-baker-ph-d","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Felix J. Baker, Ph.D.","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:7:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:g-bradley-cole","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"G. Bradley Cole","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:kimberly-j-popovits","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Kimberly J. Popovits","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:9:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:m-cantey-boyd","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Meredith S. Boyd","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:10:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:richard-s-levy-m-d","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Richard S. Levy, M.D.","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:11:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:sanj-k-patel","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Sanj K. Patel","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:12:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:stephen-r-biggar-ph-d","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Stephen R. Biggar, Ph.D.","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:thomas-r-malley","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Thomas R. Malley","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2016-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:14:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"seat_on","from_id":"alpha:person:tracey-l-mccain","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Tracey L. McCain","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"committee_of","from_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:audit","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Audit","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21","evidence_ids":["alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad","alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:chairs:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21:committee:kiniksa-pharmaceuticals-international-plc:audit","relationship_type":"chairs","from_id":"alpha:person:thomas-r-malley","to_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:audit","from_label":"Thomas R. Malley","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21","evidence_ids":["alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad"]},{"relationship_id":"alpha:relationship:member_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21:committee:kiniksa-pharmaceuticals-international-plc:audit","relationship_type":"member_of","from_id":"alpha:person:g-bradley-cole","to_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:audit","from_label":"G. Bradley Cole","to_label":"Audit","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21","evidence_ids":["alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"committee_of","from_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:audit-chair","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Audit · Chair","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2016-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:member_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13:committee:kiniksa-pharmaceuticals-international-plc:audit-chair","relationship_type":"member_of","from_id":"alpha:person:thomas-r-malley","to_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:audit-chair","from_label":"Thomas R. Malley","to_label":"Audit · Chair","valid_from":"2016-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"committee_of","from_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:compensation","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Compensation","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25","evidence_ids":["alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad","alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:chairs:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25:committee:kiniksa-pharmaceuticals-international-plc:compensation","relationship_type":"chairs","from_id":"alpha:person:kimberly-j-popovits","to_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:compensation","from_label":"Kimberly J. Popovits","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25","evidence_ids":["alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad"]},{"relationship_id":"alpha:relationship:member_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25:committee:kiniksa-pharmaceuticals-international-plc:compensation","relationship_type":"member_of","from_id":"alpha:person:m-cantey-boyd","to_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:compensation","from_label":"Meredith S. Boyd","to_label":"Compensation","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25","evidence_ids":["alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"committee_of","from_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:compensation-chair","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Compensation · Chair","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:member_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8:committee:kiniksa-pharmaceuticals-international-plc:compensation-chair","relationship_type":"member_of","from_id":"alpha:person:kimberly-j-popovits","to_id":"alpha:committee:kiniksa-pharmaceuticals-international-plc:compensation-chair","from_label":"Kimberly J. Popovits","to_label":"Compensation · Chair","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:15:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"executive_of","from_id":"alpha:person:eben-tessari","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Eben Tessari","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2026-04-16","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:16ab3874995173b77b20cc5299cd3af3ebadeb372c0541eb1da7103d812effc5"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:16:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"executive_of","from_id":"alpha:person:john-f-paolini","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"John F. Paolini","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2026-04-16","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:4dea3fbb2b2db9cd44e3cc8688f93623c90cb4d554e102333cd604bb718baf37"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:17:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"executive_of","from_id":"alpha:person:mark-ragosa","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Mark Ragosa","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2026-04-16","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:17","evidence_ids":["alpha:projection-evidence:document:d9e4db646bc39ea68ef6182197ff9bb92f94f6b49e3b40234e69d662e0ac9ef5"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:18:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"executive_of","from_id":"alpha:person:michael-megna","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Michael Megna","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2026-04-16","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:fe47d0f47e092d3b20c3e325b8dad5e00d63c36f15b508b5f75fe7d727287089"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:19:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"executive_of","from_id":"alpha:person:ross-moat","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Ross Moat","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2026-04-16","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:19","evidence_ids":["alpha:projection-evidence:document:5832c838c0e7cd3b8ec0b3752fdcab84324bc816406bee9124ae6fc55374d9a8"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:20:company:9011f721-f68e-4a71-b1b5-e505201f81cf","relationship_type":"executive_of","from_id":"alpha:person:sanj-k-patel","to_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","from_label":"Sanj K. Patel","to_label":"Kiniksa Pharmaceuticals International, plc","valid_from":"2026-04-16","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:20","evidence_ids":["alpha:projection-evidence:document:1abd925ef4dfe4186e183b05f87763002497554775e404a250d5189ba10580c0"]}]},"claims":[{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:5","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:barry-d-quart-pharm-d","object_label":"Barry D. Quart, Pharm.D.","object_source_name_forms":[],"value":"Barry D. Quart, Pharm.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:barry-d-quart-pharm-d","name":"Barry D. Quart, Pharm.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:6","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:felix-j-baker-ph-d","object_label":"Felix J. Baker, Ph.D.","object_source_name_forms":[],"value":"Felix J. Baker, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:felix-j-baker-ph-d","name":"Felix J. Baker, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:7","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:g-bradley-cole","object_label":"G. Bradley Cole","object_source_name_forms":[],"value":"G. Bradley Cole: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:g-bradley-cole","name":"G. Bradley Cole"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kimberly-j-popovits","object_label":"Kimberly J. Popovits","object_source_name_forms":[],"value":"Kimberly J. Popovits: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kimberly-j-popovits","name":"Kimberly J. Popovits"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:9","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:m-cantey-boyd","object_label":"Meredith S. Boyd","object_source_name_forms":[],"value":"Meredith S. Boyd: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:m-cantey-boyd","name":"Meredith S. Boyd"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:10","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-s-levy-m-d","object_label":"Richard S. Levy, M.D.","object_source_name_forms":[],"value":"Richard S. Levy, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-s-levy-m-d","name":"Richard S. Levy, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:11","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sanj-k-patel","object_label":"Sanj K. Patel","object_source_name_forms":[],"value":"Sanj K. Patel: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sanj-k-patel","name":"Sanj K. Patel"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:12","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:stephen-r-biggar-ph-d","object_label":"Stephen R. Biggar, Ph.D.","object_source_name_forms":[],"value":"Stephen R. Biggar, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:stephen-r-biggar-ph-d","name":"Stephen R. Biggar, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:thomas-r-malley","object_label":"Thomas R. Malley","object_source_name_forms":[],"value":"Thomas R. Malley: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:thomas-r-malley","name":"Thomas R. Malley"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:14","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tracey-l-mccain","object_label":"Tracey L. McCain","object_source_name_forms":[],"value":"Tracey L. McCain: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tracey-l-mccain","name":"Tracey L. McCain"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:15","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eben-tessari","object_label":"Eben Tessari","object_source_name_forms":[],"value":"Eben Tessari: Executive Vice President and Chief Strategy Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:eben-tessari","name":"Eben Tessari"},"title":"Executive Vice President and Chief Strategy Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-16","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:16ab3874995173b77b20cc5299cd3af3ebadeb372c0541eb1da7103d812effc5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:27.610091+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16T00:00:00+00:00","effective_from":"2026-04-16","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:16","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-f-paolini","object_label":"John F. Paolini","object_source_name_forms":[],"value":"John F. Paolini: Executive Vice President and Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-f-paolini","name":"John F. Paolini"},"title":"Executive Vice President and Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-16","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:4dea3fbb2b2db9cd44e3cc8688f93623c90cb4d554e102333cd604bb718baf37","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:26.393565+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16T00:00:00+00:00","effective_from":"2026-04-16","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:17","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-ragosa","object_label":"Mark Ragosa","object_source_name_forms":[],"value":"Mark Ragosa: Executive Vice President and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mark-ragosa","name":"Mark Ragosa"},"title":"Executive Vice President and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-16","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:d9e4db646bc39ea68ef6182197ff9bb92f94f6b49e3b40234e69d662e0ac9ef5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:26.989862+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16T00:00:00+00:00","effective_from":"2026-04-16","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:18","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-megna","object_label":"Michael Megna","object_source_name_forms":[],"value":"Michael Megna: Senior Vice President, Chief Accounting Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-megna","name":"Michael Megna"},"title":"Senior Vice President, Chief Accounting Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-16","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:fe47d0f47e092d3b20c3e325b8dad5e00d63c36f15b508b5f75fe7d727287089","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:25.184549+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16T00:00:00+00:00","effective_from":"2026-04-16","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:19","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ross-moat","object_label":"Ross Moat","object_source_name_forms":[],"value":"Ross Moat: Executive Vice President and Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ross-moat","name":"Ross Moat"},"title":"Executive Vice President and Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-16","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:5832c838c0e7cd3b8ec0b3752fdcab84324bc816406bee9124ae6fc55374d9a8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:25.75586+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16T00:00:00+00:00","effective_from":"2026-04-16","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:20","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sanj-k-patel","object_label":"Sanj K. Patel","object_source_name_forms":[],"value":"Sanj K. Patel: Chief Executive Officer and Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sanj-k-patel","name":"Sanj K. Patel"},"title":"Chief Executive Officer and Chairman of the Board","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-16","valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:document:1abd925ef4dfe4186e183b05f87763002497554775e404a250d5189ba10580c0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:24.569303+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-16T00:00:00+00:00","effective_from":"2026-04-16","effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Thomas R. Malley; Members Thomas R. Malley (Chair); G. Bradley Cole; Tracey L. McCain","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Thomas R. Malley","members":[{"display_name":"Thomas R. Malley","person_slug":"thomas-r-malley","is_chair":true},{"display_name":"G. Bradley Cole","person_slug":"g-bradley-cole","is_chair":false},{"display_name":"Tracey L. McCain","person_slug":"tracey-l-mccain","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25","subject_id":"alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Kimberly J. Popovits; Members Kimberly J. Popovits (Chair); Meredith S. Boyd","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Kimberly J. Popovits","members":[{"display_name":"Kimberly J. Popovits","person_slug":"kimberly-j-popovits","is_chair":true},{"display_name":"Meredith S. Boyd","person_slug":"m-cantey-boyd","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:51:55.971604+00:00","sources":[{"id":"alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16","retrieved_at":"2026-04-24T23:31:01.873+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:16ab3874995173b77b20cc5299cd3af3ebadeb372c0541eb1da7103d812effc5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:27.610091+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4dea3fbb2b2db9cd44e3cc8688f93623c90cb4d554e102333cd604bb718baf37","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:26.393565+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d9e4db646bc39ea68ef6182197ff9bb92f94f6b49e3b40234e69d662e0ac9ef5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:26.989862+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fe47d0f47e092d3b20c3e325b8dad5e00d63c36f15b508b5f75fe7d727287089","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:25.184549+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5832c838c0e7cd3b8ec0b3752fdcab84324bc816406bee9124ae6fc55374d9a8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:25.75586+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1abd925ef4dfe4186e183b05f87763002497554775e404a250d5189ba10580c0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KNSA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":"2026-04-16T00:00:00+00:00","retrieved_at":"2026-05-16T04:32:24.569303+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.849,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.904,"cross_source_agreement":0.75,"temporal_completeness":0.762},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":21,"temporal_claims_with_valid_from":16,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:51:55.971604+00:00","observed_at":"2026-10-16T13:51:55.971604+00:00","reviewed_at":"2026-10-16T13:51:55.971604+00:00","verified_at":"2026-10-16T13:51:55.971604+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/kiniksa-pharmaceuticals-international-plc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}